Avanos Medical (AVNS) Cash & Equivalents (2016 - 2024)
Historic Cash & Equivalents for Avanos Medical (AVNS) over the last 12 years, with Q3 2024 value amounting to $89.0 million.
- Avanos Medical's Cash & Equivalents fell 1690.01% to $89.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $89.0 million, marking a year-over-year decrease of 1690.01%. This contributed to the annual value of $87.7 million for FY2023, which is 3132.34% down from last year.
- According to the latest figures from Q3 2024, Avanos Medical's Cash & Equivalents is $89.0 million, which was down 1690.01% from $92.2 million recorded in Q2 2024.
- Over the past 5 years, Avanos Medical's Cash & Equivalents peaked at $187.7 million during Q1 2020, and registered a low of $75.8 million during Q1 2024.
- Moreover, its 5-year median value for Cash & Equivalents was $104.3 million (2022), whereas its average is $114.0 million.
- Per our database at Business Quant, Avanos Medical's Cash & Equivalents crashed by 4667.02% in 2021 and then skyrocketed by 1963.19% in 2022.
- Quarter analysis of 5 years shows Avanos Medical's Cash & Equivalents stood at $111.5 million in 2020, then increased by 6.28% to $118.5 million in 2021, then increased by 7.76% to $127.7 million in 2022, then tumbled by 31.32% to $87.7 million in 2023, then grew by 1.48% to $89.0 million in 2024.
- Its Cash & Equivalents was $89.0 million in Q3 2024, compared to $92.2 million in Q2 2024 and $75.8 million in Q1 2024.